Boundless Bio, Inc.: 1 tracked 2026 layoff event(s), 0 workers counted, highest AI score 5.
AI score 5 (80% interval 4–6) · evidence grade D · US · Pharma / Chemicals
Stated reason: On June 23, 2026, Boundless Bio, in connection with signing of the Merger Agreement, announced a workforce reduction of approximately 75% of Boundless Bio’s workforce. Boundless Bio expects to incur one-time costs of approximately $3.0 million to $5.0 million in connection with the workforce reduction primarily related to one-time termination benefits (some of which are contractual), including severance and healthcar…
Why 5: Merger / acquisition integration · Drivers: industry AI exposure +0.5, contrary evidence −0.2, role AI exposure +0.1
Signals: attribution 0.0, primary 0.0, exec 0.0, role exposure 0.653, industry exposure 0.712, AI investment 0.0, contrary 0.15 · typical Health Care & Pharma roles (no roles named)
Headcount basis: not disclosed
Company AI financials (AI spending, revenue, earnings-call AI mentions) are coming soon to this page.
